Scientists at The Florey have developed a formulation that has been proven to alleviate deadly sepsis. Sepsis is difficult to treat and often fatal, accounting for a significant number of hospital deaths. The formulation, called sodium ascorbate, is a pH-balanced formulation of vitamin C, which has shown promising results in treating sepsis. In an initial clinical trial at the Austin Hospital in Melbourne, patients who received sodium ascorbate intravenously showed improvements in multiple organs. The next phase of clinical trials will be conducted across Australia to determine the effectiveness of the formulation. Sepsis is a major cause of death in intensive care units worldwide, and an effective treatment would be a game-changer. The researchers have spent years investigating sepsis and have seen dramatic results in preclinical studies, with high doses of sodium ascorbate resulting in full recovery within three hours. The potential of this treatment is exciting and could save many lives.
https://florey.edu.au/news/2023/10/remarkable-medical-discovery-for-sepsis-moves-to-next-phase-of-human-trials/